Place H M, Enzenauer R J, Muff B J, Ziporin P J, Brown C W
Orthopedic Surgery Service, Fitzsimons Army Medical Center, Aurora, Colorado, USA.
Spine (Phila Pa 1976). 1996 Oct 1;21(19):2268-72. doi: 10.1097/00007632-199610010-00018.
This was a retrospective review of 49 consecutive patient charts and a prospective study of 44 consecutive patients who underwent spinal fusion.
To determine the incidence and clinical significance of hypomagnesemia after spinal fusion.
Hypomagnesemia may be seen in 61% of patients in postoperative intensive care and may be associated with increased mortality. However, symptomatic hypomagnesemia is rare.
A retrospective review of the charts of 49 consecutive patients who underwent spine fusion was completed to determine postoperative magnesium levels. Twenty-seven patients with postoperative hypomagnesemia received routine magnesium replacement regardless of symptoms. Forty-four patients who underwent spine fusion were studied prospectively for postoperative hypomagnesemia. Prospectively studied observational patients who developed hypomagnesemia were treated only when clinical signs or symptoms of magnesium deficiency occurred.
Postoperative hypomagnesemia occurred in 28 of 49 retrospectively studied patients who underwent spine fusion (57%) and 38 of 44 prospectively studied patients who underwent spine fusion (86%). Symptoms associated with hypomagnesemia developed in three of 44 prospectively studied and two of 49 retrospectively studied patients who underwent spine fusion (7% and 4%, respectively). The combined incidence for symptomatic hypomagnesemia was five of 93 patients. (5.4%). The majority of patients from the prospective study with postoperative hypomagnesemia were asymptomatic, and their magnesium levels returned to normal within 4 days, with or without treatment.
This study confirmed a high incidence of hypomagnesemia in patients who underwent spine fusion, although only 5.4% developed clinical signs or symptoms of magnesium deficiency. The cause of hypomagnesemia remains speculative.
这是一项对49例连续患者病历的回顾性研究以及对44例连续接受脊柱融合术患者的前瞻性研究。
确定脊柱融合术后低镁血症的发生率及其临床意义。
术后重症监护病房中61%的患者可能出现低镁血症,且可能与死亡率增加有关。然而,有症状的低镁血症很少见。
完成对49例连续接受脊柱融合术患者病历的回顾性研究以确定术后镁水平。27例术后低镁血症患者无论有无症状均接受常规镁补充治疗。对44例接受脊柱融合术的患者进行前瞻性研究以观察术后低镁血症情况。对前瞻性研究中出现低镁血症的观察患者,仅在出现镁缺乏的临床体征或症状时才进行治疗。
在回顾性研究的49例接受脊柱融合术患者中,28例出现术后低镁血症(57%);在前瞻性研究的44例接受脊柱融合术患者中,38例出现术后低镁血症(86%)。在44例前瞻性研究和49例回顾性研究的接受脊柱融合术患者中,分别有3例和2例出现与低镁血症相关的症状(分别为7%和4%)。有症状的低镁血症的合并发生率为93例患者中的5例(5.4%)。前瞻性研究中大多数术后低镁血症患者无症状,无论是否接受治疗,其镁水平在4天内恢复正常。
本研究证实接受脊柱融合术的患者中低镁血症发生率很高,尽管只有5.4%的患者出现镁缺乏的临床体征或症状。低镁血症的原因仍属推测。